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INTRODUCTION 
EPIDEMIOLOGY: 
 Perinatal hypoxia is one of the leading contributor to both neonatal 
mortality and neurodevelopmental disability. The reported incidence of 
perinatal hypoxia in developed countries is around 1-1.5%.  
The incidence of perinatal hypoxia reported in India is higher ie., around 
2.5% according to NNPD 2000 data.  
Perinatal hypoxia contributes to major share of neonatal deaths in India – 
nearly 20% of neonatal mortality. If still births were included the contribution 
from perinatal hypoxia will increase further. 
THERAPEUTIC HYPOTHERMIA: 
 Until recently recently there is no specific treatment for perinatal 
hypoxia. Treatment basically involves supporting the organ systems. There 
were immense clinical research in various neuroprotective strategies in perinatal 
hypoxia.  
Among these therapeutic hypothermia holds  promise. Within a short 
span of time therapeutic hypothermia become a standard of care and in many 
western countries registry maintained nationwide for this new procedure. 
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 Indeed therapeutic hypothermia was mentioned in neonatal resuscitation 
protocol by American academy of paediatrics. 
 Feasibility trial done in CMC vellore acknowledge to the fact that this 
procedure could be adapted to a low cost setting in a safe manner . 
In this method newborns suffering from moderate to severe 
encephalopathy would be intentionally subjected to a controlled hypothermia 
for 72 hrs. 
 Follow up studies(TOBY TRIAL) at 18 months showed better 
neurodevelopmental outcome. Assessment of neurodevelopment at school 
age(TOBY TRIAL FOR CHILDREN) is still on the way. 
 If this technology could be adapted to a low cost form it would benefit a 
great number of newborns in developing countries like India. 
 EEG is an valuable investigation in that it can assess the function of the 
brain unlike other imaging studies. EEG is used in perinatal hypoxia to grade 
the severity, to prognostic the developmental outcomes, to identify seizures .  
In this study I analysed the EEG records of those babies who underwent 
therapeutic hypothermia as a treatment for hypoxic ischemic encephalopathy 
from the month of May 2012 to november 2012 in Chengalpattu medical 
college neonatal intensive care unit – a level II nicu setting and the statistics 
were presented. 
12 
 
 
INTRODUCTION TO THERAPEUTIC HYPOTHERMIA: 
HISTORY: 
  The concept of using cooling the body as a treatment strategy was an age 
old one. It was even during age old period Hippocrates – Father of Medicine 
advised regarding the use of ice to reduce the swelling among wounded 
soldiers. 
 One of the surgeons of the great warrior Napoleon made an interesting 
observation during the periods of war. According the soldiers of higher cadre 
who were sheltered near the fire tend to die more frequently than the ordinary 
low grade soldiers who were left in the cold to suffer. 
THERAPEUTIC HYPOTHERMIA IN ADULTS: 
 One of the first article regarding therapeutic hypothermia appeared in 
1945. Then scientific people lost interest in it. Animal experiments involving 
therapeutic hypothermia was conducted in 1984.  
The Skiing accident of Anna Begholm who was resuscitated after a long 
period of cardiac arrest from the ice cold water arose interest among scientist 
about the neuroprotective possibility of hypothermia in cardiac arrest situations. 
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 Nowadays therapeutic hypothermia  is a recognized treatment option for 
cardiac arrest patients in adults. In 2002 the American heart association and 
ILCOR – international liason and committee on resuscitation endorsed the 
procedure of therapeutic hypothermia for cardiac arrest patients. 
 Inducing therapeutic hypothermia in adults is limited to few centers in 
developed countries. Therapeutic hypothermia is also tried in few other clinical 
scenarios- head injury, traumatic spinal cord injury, stroke, neurogenic fever. 
 
THERAPEUTIC HYPOTHERMIA IN NEONATES: 
 The scenario of therapeutic hypothermia for perinatal asphyxia is 
somewhat different. Initially few scientist were involved in animal experiments 
for the effect of hypothermia in thyroid function.  
The experiments evolved to analyzing the hypothermia effects in 
asphyxiated animals in piglets and sheep by using complex gadgets like 
magnets resonance spectroscopy analysis and also simple instruments like EEG.  
 The first pilot study on the effect of therapeutic hypothermia was 
conducted in human babies in New Zealand in 1998 and prove to the point that 
the procedure was safe and it is really a feasible option. 
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THERAPEUTIC HYPOTHERMIA CLINICAL TRIALS: 
 Suddenly interest in the concept of neuroprotective effect of therapeutic 
hypothermia spread to many countries. Subsequent pilot studies were conducted 
in Australia, US, Turkey, China.Three major multicentered randomized clinical 
trials –COOL CAP STUDY, NICHD STUDY, TOBY STUDY about the period 
of 2003-2005 in countries such as US,UK, New Zealand and  Australia. 
 
THERAPEUTIC HYPOTHERMIA TRIAL RESULTS: 
 In 2007 Cochrane group analysed the metaanalysis of the report 
particularly that of TOBY trial and concluded that although therapeutic 
hypothermia does not reduce the mortality and severe neurodevelopmental 
sequale therapeutic hypothermia is associated with a better neurodevelopmental 
outcomes. 
 
ENDORSEMENT OF THERAPEUTIC HYPOTHERMIA: 
 Subsequently many hospitals particularly those countries and centers 
involved in the trials were started offering therapeutic hypothermia as a 
treatment option for perinatal asphyxiated neonates. 
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 In many of this developed countries national registry exists for providing 
uniformity in the treatment of therapeutic hypothermia in various hospitals. The 
number of hospitals providing therapeutic hypothermia constantly growing 
since then. 
 In developed countries therapeutic hypothermia is induced by a servo 
control machine than regulates the temperature of the water in the blanket. The 
baby will be kept over the blanket.  
In US there is a tendency to monitor the core temperature of the baby 
during the cooling procedure by oesophageal thermometer as it more closer to 
brain. 
 Instead in UK rectal probe was used to measure the core temperature. 
Therapeutic hypothermia is endorsed by NICE –UK and also recommended in 
neonatal resuscitation protocols by American academy of paediatrics. 
THERAPEUTIC HYPOTHERMIA USING LOW COST TECHNOLOGY: 
 The high prevalence of perinatal asphyxia and its attended high mortality 
and high morbidity in developing countries arouse serious interest in this new 
technology. 
 Anectodally developing countries like India, South Africa, China were 
conducting clinical trials in therapeutic hypothermia for perinatal asphyxiated 
newborns. 
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THERAPEUTIC HYPOTHERMIA IN INDIA: 
 In India study conducted by Dr.Niranjan Thomas of CMC vellore proved 
to the point that therapeutic hypothermia can be induced by a low cost 
technology such as gel packs and vaccine carriers in an effective and safe 
manner.  
Indeed even in those centers were therapeutic hypothermia is induced by 
servo control machine babies were used to cooled by gel packs while during the 
inter hospital transport. So the concept of inducing therapeutic hypothermia by 
gel packs is not entirely new one. 
 The average cost of servo control machine involved in therapeutic 
hypothermia would be around 35 lakhs interms of Indian money. Comparatively 
inducing hypothermia by gel packs is relatively much cheaper and feasible 
option which also doen’t need expertise management. 
 There are interests in Phase contrast materials which tend to retain the 
temperature relatively stable than the gel packs.  
 Various ingineous low cost technology in inducing hypothermia was 
tried. For example in one of the African countries water bottles was used to 
induce hypothermia and in one another study electrical fan was used. 
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Ìn India CMC Vellore and Jipmer Pondicherry were pionnerring in this 
field of therapeutic hypothermia. Jipmer have produced several molecular 
studies proving the neuroprotective efficacy of therapeutic hypothermia in 
perinatal asphyxia. 
    National wide conferences and indeed workshops are being conducted 
in India regarding this new technology of therapeutic hypothermia. 
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AIM OF THE STUDY: 
 To analyse the EEG pattern of neonates who suffered hypoxic ischemic 
encephalopathy and underwent therapeutic hypothermia as a treatment 
modality. 
OBJECTIVE OF THE STUDY 
 1.To identify subclinical seizures and follow them with developmental 
assessment, clinical neurological examinations, anthropometric measurements. 
 2. To identify abnormalities in EEG associated with clinically suspected 
seizures and thereby treating with anticonvulsants. 
 3. To identify abnormalities in EEG associated with developmental delay 
concerns. 
 4.To have a baseline EEG record so that follow up serial EEG assessment 
can be made to prognosticate neurodevelopmental outcome in perinatal 
hypoxia. 
 5.To identify any EEG abnormalities associated with structural 
abnormalities. 
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MATERIALS AND METHODS: 
 Those babies who underwent therapeutic hypothermia as a treatment for 
moderate to severe encephalopathy would be qualified to undergo EEG testing 
at the age of one month. 
 In our institution from the month of May 2012 to November 2012 about 
129 term newborns were admitted for moderate to severe hypoxic ischemic 
encephalopathy. 
 Of these 129 newborns 42 babies were delivered in institutions other 
than Chengalpattu Medical College Hospital and reffered here. Remaining 87 
were delivered in our institution.  
Out of the total 129 babies about 50 babies underwent therapeutic 
hypothermia after getting informed consent and satisfying the inclusion criteria.  
There is no random allocation between cooled and non cooling groups. 
Every babies satisfying the inclusion criteria will be offered therapeutic 
hypothermia as a treatment option. 
 
 
 
  
 
cooled-50
inborn-37
survived-24 died-13 survived 6
20 
total 129
outborn-13
died-7
inborn-50
survived-31 died-19
 
non cooled 
- 79
outborn-29
survived-19 died-13
  
 
 
INCLUSION CRITERIA:
1. Term(>36wks)  
2. Birthweight > or equal to 2000g
3. Apgar score of less than or equal to 5 at the age of 10 mins of life
4. less than 6 hrs of life
5. features of moderate to severe encephalopathy as classified by levene 
staging of hypoxic ischemic encephalopathy.
6. Prolonged need for ventilator assistance 
ventilation or Endotracheal intubation even after 10 minutes of life.
cooled-50
survived-
30
died20
21 
 
 
 
 
– either by bag and mask 
total 129
non 
cooled-79
survived-
47
 
 
 
died-32
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EXCLUSION CRITERIA: 
1. Refusal of consent 
2. >6 hrs of life on admission or features of encephalopathy diagnosed at  
>6 hrs of life 
3. major congenital anomalies 
4. inability to intiate cooling by 6 hrs of age 
After satisfying the inclusion and exclusion criteria those babies selected 
for therapeutic hypothermia will be started on cooling as quickly as possible. 
Cooling was done by gel packs and vaccine carries. 
 Gel packs and vaccine carriers would be kept in refrigerator before 
use.Gel packs and vaccine carriers will covered with clean cloth and kept 
around the baby which has to be cooled. 
 A rectal probe PHILIPS –ref no 21090A was used to constantly monitor 
the rectal temperature. The probe will be inserted about 5 cm into the rectum 
from the anal margin  All the vital parameters will be monitored continuously. 
 The gel packs and vaccine carriers would be constantly removed and 
replaced around the baby so that the core temperature would be around 33-34 
celcius with an acceptable range of 32.5 to 34.5 celcius. 
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 This particular target temperature 33-34 degree celcius will be 
maintained for the next 3 days or 72 hrs. Babies will be constantly repositioned 
to avoid subcutaneous fat necrosis. 
Bladder will be cathetrised to monitor urine output. Prothrombin time and 
activate partial thromboplastin time will be assessed for coagulopathy. If 
coagulopathy is found fresh frozen plasma will be transfused and the 
investigation would be repeated.  
Other blood investigation would be done as per the standard management 
of perinatal hypoxia.Monitoring during the cooling and rewarming period will 
be documented in the specially modified monitoring charts. 
 At the end of 72 hrs babies would be gradually rewarmed over a period of 
10 hrs with the temperature increasing not more than 0.5 celcius per hour to 
avoid rebound hyperthermia. 
 Data regarding the babies who underwent the therapeutic hypothermia 
would be collected  and analysed systematically. The residential address and 
phone numbers of the parents will be collected. 
 The date for EEG examination of the baby will be fixed just before the 
baby gets discharged and the parents will be informed  both orally and written 
forms regarding the date of EEG examination. 
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Occasionally babies may require sedation during the procedure of 
recording EEG . In that case Chloral hydrate – which will not affect the EEG 
patterns was used. 
Every baby would undergo imaging in the form of ultrasound cranium 
before getting discharged. Parents will be given follow up book made for nicu 
graduates of our institution. 
EEG will be recorded in the EEG unit of Neurology Department of our 
Institution and the data will be maintained. EEG will be analysed by 
Neurologist and the results are communicated to the parents and the need for 
regular follow up visit is also instructed. 
 Developmental screening of the babies who underwent therapeutic 
hypothermia was planned. Developmental screening was done by using DDST 
II Denver Developmental Screening Test by me. 
 DDST screening for all these babies were done in the month of 
December 2012 in two session with the average time taken for each babies was 
10 minutes. So babies of various age groups – from one month age to 7 months 
were tested by DDST.  
Parents were called to attend the screening test by phone. The nature of 
the screening test and the results of the test were instructed to the parents. 
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 During this developmental assessment follow up, head circumference and 
the weight of the baby was also measured. Weight of the babies were measured 
using taring scales.z scores of the head circumference and weight of the baby 
will be derived from the free software ANTHRO provided by WHO official 
website. 
REVIEW OF LITERATURE: 
PERINATAL HYPOXIA: 
 Neonatal mortality is high in India as in many developing countries. The 
neonatal mortality is about 36/1000 live births in India-and about 23/1000 live 
births in the state of Tamil Nadu- Sample registration System-Statistical Report 
2007 Ministry of Home Affairs New Delhi. 
 Neonatal mortality rate in India – 32/1000 live births – WHO REPORT 
2010. Total number of neonatal deaths in India during the year 2010 – 8,75,000. 
 Data regarding the contribution of perinatal hypoxia to the neonatal 
deaths were obtained from hospitalized babies. 
 Among intramural babies perinatal asphyxia contributes more than 50% 
of mortality and among extramural babies perinatal asphyxia contributes to 
nearly 49% of neonatal moratlity.- National Neonatal and Perinatal Database 
NNPD 2002-2003. 
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 Thus in India perinatal hypoxia is a leading cause of neonatal mortality. 
It is assumed that perinatal mortality contributes to nearly 20% of neonatal 
mortality overall in India, 
 According to NNPD 2000 data about 2.5% babies continued to have 
Apgar score of less than 7 at 5 minutes of age. Thus the prevalence of perinatal 
hypoxia and its consequences are relatively high in India compared to 
developed countries. 
 Among the survivors of perinatal asphyxia 5-10% may develop cerebral 
palsy compared to the risk of only 0.2% in the general population. 
THERAPEUTIC HYPOTHERMIA: 
HISTORY: 
 Hypothermia as a treatment modality is not new to mankind. It was even 
during age old time that Hippocrate advised to use ice packs for wounded 
soldiers. 
 An interesting observation by one the Naploean’s surgeon Dominique 
Jean larrey was that officers who sheltered near fire survived less often than 
lower grade soldiers during the period of war. 
 The first medical article regarding use of hypothermia in the treatment 
appeared in 1945 in which hypothermia was used in head injury patients. 
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  Doctor Rosomoff demonstrated the neuroprotective beneficial effects of 
hypothermia in dogs in 1950s. 
 Skiing accident of Anna Bagenholm in 1999 is an important milestone in 
therapeutic hypothermia. 
 Besides animal studies and human accidents the first human experiments 
regarding therapeutic hypothermia appeared in 2002.-Holzer, Michael-“ Mild 
hypothermia to improve the neurologic outcome after cardiac arrest”New 
England Journal of Medicine. 2002 vol.346 no.8 
 In 2003 American Heart Association and International Liason Committee 
on resuscitation endorsed the application of therapeutic hypothermia as a 
treatment modality for cardiac arrest candidates in adults. 
 Along with this various experiments involving neuroprotective role of 
various drugs were suggested as a treatment modality for therapeutic 
hypothermia. 
 Vannuci RC, Current and potentially new management strategies for 
perinatal hypoxia ischemic encephalopathy. Paediatrics 1990;85:961-8 
 Du-Pleiss and Johston explored the cellular mechanism and potential 
strategies for neuroprotection- Clinics in perinatology 1997:29.627-654 
 In one of the trials high dose phenobarbitone was tried as a 
neuroprotective statergy- Hall RT, Hall FK, Daily DK - J Paediatr 1998;345-8 
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 Agents such as ketamine,MK-80, allopurinol, superoxide dismutase and 
vitamin E; Ca channel blockers – nimodipine,nicardipine; cyclooxygenase 
inhibitor such as indomethacin; benzodiazepine receptor stimulation such as 
midazolam; and protein synthesis enhancers such as dexamethosone have been 
tried in animal experiments as a neuroprotective strategy in perinatal hypoxia.  
These experiments have few or no human experimental data. 
 Xenon and Erythropoietin are promising agents in this front and they are 
in Phase I clinical trial and in one major trial is conducted along with 
therapeutic hypothermia for its possible synergestic benefit.Xe-hypotheca trial-
Turku university hospital. 
 TOBY one of the major clinical trials involved in therapeutic 
hypothermia in perinatal asphyxia is now conducting trial (TOBY Xenon -2009-
2012) in the beneficial neuroprotective effects of Xenon. 
THERAPEUTIC HYPOTHERMIA IN NEONATES – EVOLUTION: 
1.Gluckman and Gunn – endocrinologist – University of Auckland New 
Zealand – interested in cooling for its effect on thyroid function. 
2.Reynold group conducted hypothermia experiments in newborn piglets-1994 
“Delayed (secondary) cerebral energy metabolism and infaction following acute 
hypoxia-ischaemia in the newborn piglet continous 48 hour studies by 31P 
magnetic resonance spectroscopy” Paediatr Res 36(6) 699-706 
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3.Alistair gunn and Chris Williams conducted hypothermia experiments in fetal 
sheep-1992 “Outcome after ischemia in the developing sheep brain: an 
electroencephalographic and histological study”Ann Neurol 31(1):14-21 
 
4.1998- The first pilot randomized control trial of therapeutic hypothermia was 
conducted in Newzealand. It included 31 newborn infants with HIE. This 
milestone experiment was demonstration of the proof of principal, feasibility in 
humans. This experiment arouse intense curiosity and was followed by 4 other 
pilot trials from U.S, Australia, Turkey and China. 
5. 2005 Three separate multicenter randomized control trials – conducted in 
US,UK,Australia, New Zealand 
 a.) The Cool Cap Study – the first infant was enrolled on july 1999 ; full 
publication in The Lancet in 2005 – no significant beneficit in reducing death or 
disability at 18 months but benefit was shown when infants with severe or long 
established neuronal damage was excluded from the study. 
 b.) The National Institute of Child Health and Human Development 
Study led by Seetha Shankaran – NICHD trial found a significant benefit. The 
study was critised for temperature instability in the control group. 
 c.) TOBY Trial –Total Body hypothermia for perinatal asphyxia trial led 
by Azzopardi- six year study from September 2002- August 2008.  
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Recruitment to TOBY ended on 30th November 2006 and its 18 month Follow 
up was completed in autumn 2008. The results of the trial was published in New 
England Journal of Medicine in October 1,2009;361:1349-1358 
 The clinical trial arrived at a final conclusion that moderate hypothermia 
for 72 hours in infants who had perinatal asphyxia did not significantly reduce 
the combined rate of death or severe disability but resulted in improved 
neurologic outcomes in survivors.-BIO MED CENTRAL BMC Paediatrics 
2008,8:17 doi:10.1186/1471-2431-8-17 
 The number needed to treat of 8 for intact survival and 14 for mortality is 
remarkable for any medical theraphy. 
 6.TOBY CHILDREN STUDY-UK Medical Research Council (MRC) – 
funded the TOBY Study also provided funding for expansion of the original 
trial with the aim of following the children who underwent therapeutic 
hypothermia upto the school age (6-7 years) 
.This is a 4 year project 2009-2013. 
The first families were allowed to participate in the trial by March 2010. The 
primary outcome of the study was to arrive at the frequency of survival with an 
IQ > or equal to 85( an IQ of 85 is 1 standard deviation below the standard. 
The results of the study is yet to be published.ISRCTN 89547571. MREC 
NUMBER:10/H0711 
31 
 
ENDORSEMENTS AND RECOGNITION OF THERAPEUTIC 
HYPOTHERMIA FOR NEONATES: 
 1.In the special report in PAEDIATRICS- the official journal of the 
American Acadaemy of Paediatrics-formulated Neonatal Resuscitation:2010 
American Guidelines for Cardiopulmonary Resuscitation and Emergency 
Cardiovascular Care-therapeutic hypothermia is mentioned as a treatment 
option. 
 2.NICE –National Institute of Health and Clinical Excellence and the 
British Association of Perinatal Medicine endorsed the application of 
therapeutic hypothermia in neonates in UK hospitals and suggests a registry. 
 3.Therapeutic hypothermia is widely used as a treatment option for 
asphyxiated neonates in countries and centres which initially participated in the 
trials. Anecdotally several other countries are also adopting cooling theraphy 
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THERAPEUTIC HYPOTHERMIA IN LOW COST SETTING – 
DEVELOPING COUNTRIES INCLUDING INDIA: 
 1.Therapeutic hypothermia using water bottles was tried as a treatment 
option in Uganda and was published in Lancet in September 2008. It reported a 
higher mortality. 
 2. A Feasibility trial was conducted in CMC vellore in India and was 
published in Indian Paediatrics in June 2011 and published online on November 
2011. 
some of the salient features of the above trial is presented here. 
the ice gel packs and vaccine carriers was used 
the adverse event reported in the study was 
cardiac arrhythmia- nil 
hypoglycemia (blood sugar <45 mg/dl) – 10% 
hyperglycemia requiring insulin --15% 
thrombocytopenia <100*10^3/ microlitre -- 25% 
bleeding -- 5% 
aposteatonecrosis -- 15% 
hypoxemia --  5% 
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hepatic dysfunction -- 5% 
Oliguria –urine output -- < 0.5 ml/kg/h 5% 
this trial also proved that the therapeutic hypothermia using low cost technology 
such as gel packs and vaccine carrriers instead of costlier servo control machine 
can be applied in a safe manner and it is also proved that the procedure is 
effective in maintaining the rectal temperature in the target range. 
 3. Robertson et al used water bottles for inducing therapeutic 
hypothermia 
 4.Horn et al used a servo control fan to maintain hypothermia. 
Both the above studies shown that cooling can be done in a low resource setting 
in a low cost technology. 
 5.Both China and South Africa trials involved applying low cost 
technology in inducing hypothermia in neonates. 
Mild hypothermia via selective head cooling as neuroprotective theraphy in 
term neonates with perinatal asphyxia: an experience from a single neonatal 
intensive care unit J Perinatology 2006:26:108-4 – Lin,Yu 
 6.JIPMER PONDICHERRY also involve in providing therapeutic 
hypothermia for perinatal asphyxia 
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therapeutic hypothermia using gel packs for term neonates with hypoxic 
ischaemic encephalopathy in resource – limited setting:- a randomized 
controlled trial by shruthi k.Bharadwaj and B.Vishnu Bhat arrived at a 
conclusion that therapeutic hypothermia using gel packs reduces the risk of 
death of developmental delay at 6 months of age in infants with HIE 
Trial registration number: CTRI/2011/06/001780 
 Various molecular studies regarding the efficacy of therapeutic 
hypothermia was also conducted in Jipmer Pondicherry-estimation of 
malondialdehyde – product of lipid peroxidation, estimation of protein carbony 
levels – general oxidative stress-Nivedita, V Bhat et al. Indian Peditr 
2010.77:515-517 
Banupriya, V Bhat et al. Science Direct 2008.41:968-973 
 DNA based studies – comet length assay by Manoj, Rao, V Bhat et al 
Curr Pediatr Res 2011;15:121-125. this study concluded that comet length 
correlate well with HIE staging and severity 
 a randomized controlled trial-effect of therapeutic hypothermia on 
oxidative stress and outcome in term neonates with  perinatal asphyxia: 
concluded that therapeutic hypothermia reduces oxidative stress in term babies 
with perinatal asphyxia and is associated with better neurological outcome. 
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 and reduction in oxidative stress could be an important mechanism by which 
therapeutic hypothermia works in HIE- Rojo Joy Femitha, P.Adhisivam, 
B.Vishnu Bhat, B.Zachariah Bobby 
  
So clinical trials conducted by CMC Vellore and JIPMER Pondicherry prove to 
the point that inducing  therapeutic hypothermia by a low cost technology such 
as gel packs and vaccine carriers is indeed possible and effective. 
 Now seminars, conferences and workshops were conducted in various 
places in India regarding therapeutic hypothermia for perinatal asphyxia. 
ETHICAL AND CONTROVERSIES SURROUNDING THERAPEUTIC 
HYPOTHERMIA: 
1. John and William discusses the efficacy and validity of therapeutic 
hypothermia in an article  named “hot debate about a cool theraphy” in 
americal neonatal journal “NEOREVIEWS” - 2009. He finally concluded  
that  therapeutic hypothermia can be offered as a treatment option 
probably and off protocol – cautiously 
2. Sudin thayyil –“Brain cooling : are we ready for clinical trials in 
developing countries?” – an article appeared in Indian Paediatrics Journal 
June 2011discusses the possible adverse consequences of therapeutic 
hypothermia in newborns 
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OUTCOME IN PERINATAL ASPHYXIA: 
 The overall mortality in perinatal mortality reported in developed 
countries is about 20% 
 The probability of neurodevelopmental sequalae in surving newborns is 
approximately 30% 
 In stage II Hypoxic ischemic encephalopathy 80% have a normal 
neurodevelopmental outcome; and abnormal if symptoms more than5-7 days 
 In stage III Hypoxic ischemic encephalopathy about 50% die; remainder 
will have severe sequelae  
 Ambalavanan N et al: predicting prognosis in neonates with hypoxic 
ischemic encephalopathy; Paediatrics 2006;118:2084-2093 developed a scoring 
system and classification system in predicting the outcome of neonate suffered 
from perinatal asphyxia. 
 The above mentioned statistics were reported from developed countries. 
With intrauterine growth restriction, low birth weight, meconium stained 
liquors, poor resuscitation at birth, poor transport at birth complicating the 
picture in developing countries like India, mortality in perinatal hypoxia would 
be expected to be much higher. 
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 The occurrence of seizures will increase the newborn’s risk of cerebral 
palsy 50 to 70 fold. Seizures occurring within less than 12 hours of life have 
increased mortality and neurodevelopmental disability rates. 
 A report suggest that seizures are common in neonates undergoing 
therapeutic hypothermia – Yap V, Engel M, Takenouchi et al 
 Reccurent seizures and Electrographic seizures are also associated with 
poorer outcomes 
 Isoelectric or low voltage activity pattern of EEG portends a poorer 
prognosis in perinatal asphyxia. 
 Recovery of a normal background activity in EEG within 7 days of life is 
associated with a normal outcome. 
 A normal EEG is a predictor good outcome even in a comatose child 
 An abnormal MRI study in less than 3 days of life also portends a poorer 
prognosis. The abnormalities usually tend to regionalize around basal ganglia, 
thalami and the posterior limb of internal capsule 
 A persistent burst suppression pattern detected in electroencephalography 
even after 7 days of life also portends a poorer prognosis. 
 Microcephaly by 3 months of age and an abnormal neurological 
examination at 12 months of life portends a poorer prognosis. In one study it 
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was suggested that rate of regression in the head growth in less than 4 months of 
age would predict eventual microcephaly and poorer neurodevelopmental 
outcome at the age of 18 months.  
Cordes I et al: Early prediction of the development of microcephaly after 
hypoxic ischemic encephalopathy in full term infants. Paediatrics 1994;93:703-
707 
 Minor delay in reading, spelling ,arithmetic ,attention,memory were 
common in the survivors of perinatal asphyxia 
 
 
 
EEG in newborn: 
 The Electroencephalogram or EEG is an important adjunctive tool in the 
assessment of infants with perinatal asphyxia. 
 It is a non invasive tool used for assessing the neonatal brain 
function.EEG is unique in a sense unlike other imaging procedures of the brain 
which provides only the anatomical details of the brain, it can provide 
functional status of the brain.  
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 Several studies have proved the prognostic role of EEG in various disease 
states such as neonatal convulsion to perinatal asphyxia and traumatic birth 
injuries and haemorrhages. 
 As neonatal brain is rapidly evolving its function as a part of normal 
maturation EEG has a greater prognostic potential than any other diagnostic tool 
available to neonatologist. 
 EEG preffered in a sense that a newborn will present with a very narrow 
behavioural and clinical abnormalities compared  adults with neurological 
abnormalities. Infantile spasm and its attended hypsarrythmia can suggested by 
specific EEG abnormalities in neonatal period prospectively. 
 EEG in newborns is applied in 
  1.diagnosis and treatment of seizures 
  2.evaluation of severity of cerebral dysfunction from primary 
neurologic disorders or systemic diseases. 
  3. Identification of specific neurological disorders 
  4. Determination of prognosis and long term neurological outcome 
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The normal neonatal EEG: 
            Interpretation of EEG in the newborn period is associated with its 
own inherent problems. EEG in a newborns differs from that of an adults 
certainly in many different ways. 
 For example gestational age should be taken into consideration while 
interpreting because EEG correlates with the gestational age of the infant 
.Some maturational changes like delta brushes, frontal sharp transients 
and temporal theta bursts are to be considered as a normal variant 
 The most marked maturational changes occur between 24 weeks 
gestational age and 1 month after term. Hence in my study EEG was taken at 
the age of one month which would eliminate the maturational changes that 
would otherwise complicate the interpretation of EEG difficult. 
. Also artefacts made by sudden movements, electrical equipments and 
the surrounding environment have to be considered. Ideally EEG in newborns 
should be supplemented with video recording of the events. 
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The abnormal neonatal electro encephalogram: 
 EEG in a neonate can manifest a wide range of abnormalities. Classifying 
the abnormalities in to diffuse and focal will makes the interpretation somewhat 
easier. 
 EEG in generally not diagnostic ie., in other words it is not very specific 
for particular disease process or causes. However birth asphyxia produces EEG 
abnormalities that resemble that of a diffuse encephalopathy pathology.EEG in 
neonates is usually described in terms of 
1. the frequency of background activity 
2. the symmetry 
3. the synchrony between both hemispheres 
4. the presence and absence of any abnormal patterns. 
Prognostic significance of Neonatal Background EEG patterns were analysed in 
various studies. 
EEG background patterns Percent with favourable outcome 
Isoelectric 0-5 
Burst suppression 0 -15 
Low voltage undifferentiated 14-3 0 
Excessively discontinuous 40-5- 
Diffuse slow activity 15-20 
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Gross asynchrony 10-20 
 
INDICATION FOR EEG IN NEWBORNS: 
 Whenever the question arise regarding the abnormal neurological status 
of the neonate an EEG examination would serve a valuable adjuctive tool. 
EEG is particularly valuable is the neonate is heavily sedated or been 
paralysed for various reason for example baby receiving fentanyl infusion while 
on mechanical ventilator support. 
 An EEG can greatly assist in discriminating between epileptic seizures 
and non epileptic events in the neonates. Non epileptic events like jitteriness is 
relatively common in neonates. 
Hence EEG is a valuable situation in this regard.EEG is the only means 
of diagnosing the frequent subtle or subclinical seizures at present. 
 As already discussed determination of subclinical seizures became 
paramount importance when the association of seizures and the association of 
poor neurodevelopmental outcome was understood. 
 An EEG should be obtained early in the lifetime of a newborn who is at 
risk for developing seizures or encephalopathy because it provide a reference 
point for future comparisons. 
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 Serial EEG instead of a single time EEG is a valuable prognostic tool as 
it can suggest the mode and timing of a brain insult to some extent. 
Serial EEGS also useful in assessing the adequacy of treatment of 
seizures with anticonvulsants and follow up examinations. 
 An expanded version of EEG with additional gadgets including 
electrocardiogram, respiration assessment, oxygenation, extraocular movements 
and electromyogram would greatly supplement the interpretation. 
 Such a exhaustive or comprehensive multichannel monitoring will 
accurately disclose the various abnormalitie, will regionalize regional or 
hemispherical cerebral activies better, and will accurately stage neonatal sleep. 
Various studies – including Tekgu et al showed that reduced montage- 9 
electrodes instead of 10/20 standard electrodes will be sensitive enough to 
detect the seizures and grading of background EEG features in newborns. 
Other EEG analysis techniques:  
 In recent days, several semi automated techniques for analyzing neonatal 
EEG have been developed’. 
For example Two Channel EEGs, Spectral edge frequency, and 
Amplitude integerated EEG. 
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Amplitude integerated EEG: 
 aEEG or amplitude integerated EEG is used predominatly in neonates 
with perinatal hypoxia and its attended hypoxic ischaemic encephalopathy. This 
technology involves employing signal processing to rectify and integerate the 
EEG amplitudes with a compressed time scale. 
 aEEG is a sensitive tool in the assessment of severely abnormal patterns. 
The sensitivity for detecting seizures was fairly good (sensitivity 80%, 
specificity- 100%) 
Spectral edge frequency: 
 This method is more appropriate for preterm neonates and it involves in 
tracking frequencies rather than amplitudes of the electrical signals . 
 The use of these new add on techniques require experience in the part of 
operator and interpretor and also frequent correlation with the routine EEGs. 
  Holmes and colleagues published an article in 1982 which concerns the 
EEG pattern assessment in perinatal asphyxiated neonates.  
They analyzed the background patterns and paroxysmal activities and 
used to extrapolate these observation to predict outcome at an average age of 24 
45 
 
months in a blinded fashion. The timing of EEG varied ; anywhere between 5 
days to a maximum of 14 days or 2 weeks . 
 A marginally abnormal or normal EEG is very reassuring. Because these 
neonates are unlikely to suffer from severe neurodevelopmental disability. 
EEG was found to be more useful in infants who have moderate to severe 
encephalopathy. 
The usefulness of EEG in infants who have hypoxic ischemic 
encephalopathy has been confirmed by multiple studies. some of them include 
1. holmes g 1982 
2. rowe j 1985 
3. thornberg e 1984 
4. hellstorm westas l 1995 
5. van lieshout h 1995 
6. Sinclair d 1995 
7. toet m 1999 
8. mcbride m 2000 
9. biagioni e 2001 
10. zeinstra e 2001 
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Shellaas RA described the sensitivity of amplitude integerated 
electroencephalography for seizure detection in the journal of Paediatrics 2007 
journal 
 prolonged seizures by itself can exacerbate the damage to the brain in 
perinatal asphyxia- Wirrell –Paediatri Res  2001 
 Those seizures which have EEG-eletroencephalography findings have a 
poor neurological outcome-Neurology journal 2000 
 In the past 30 years there have been multiple studies reporting the neuro-
developemental outcome in perinatal hypoxia. One particular literature was one 
that appeared in 1998 by Bohr and Greisen –it’s a collection from 16 studies 
performed in various countries like Japan , US and from some of the countries 
in Europe . In the study 4% have mild forms of cerebral palsy and 10% have 
developmental delay. 
 
PATHOPHYSIOLOGY BEHIND PERINATAL ASPHYXIA: 
 Normal labour will test the physiological reserve of a newborn baby. 
Surprisingly most of the babies are born with little oxygen reserve at birth. 
Many events are possibly related to this. they include 
 1.contraction of the uterus during labour may reduce the blood supply 
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 2.some degree of cord compression is a possibility’ 
 3. maternal dehydration and maternal alkalosis due to hyperventilation  
     may possibly reduce the placental blood flow 
 4, increased oxygen consumption by both the mother and the fetus 
Brief asphyxiating events produces  
 1.increase in the heart rate, elevation in blood pressure and increase in the 
central venous pressure with no ultimate change in the cardiac output. This is 
essentially increases the blood flow to vital organs such as brain, kidney- diving 
reflex. 
 2.severe but a short asphyxiating event such as placental abruption 
followed by caesarean section tends to produce a unique and characteristic 
pattern of neuronal injury that tend to localize to subcortical region and the 
brain stem nuclei 
prolonged asphyxia produces more vivid biophysical changes: 
 1.loss of autoregulation of cerebral blood flow 
 2.increase in anaerobic metabolism and eventual energy failure in cells 
 3.fall in glycogen,ATP and phosphocreatine 
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 4, prolonged asphyxiating events typically produces a diffuse injury – 
involving both cortical and subcortical structures 
 
 
Subcellular events in asphyxia include: 
1.failure of ion pumps 
2.influx of sodium, chloride, calcium 
3.excitatory neurotransmitters 
4.increased apoptosis 
5.increased oxidative stress 
reperfusion of blood supply after a period of asphyxia worsen the amount of 
neuronal damage by increasing the oxygen free radicals 
HOW DOES THERAPEUTIC HYPOTHERMIA WORK: 
Exact mechanism of therapeutic hypothermia works still eludes the researchers. 
various hypothesis suggested are 
1. reducing the cellular metabolism 
2. reducing the amount of excitotoxin 
3. stabilizing the lipid membranes 
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4. reducing free radical injury 
5. reducing the rate of apoptosis 
 
 
THE CONCEPT OF WINDOW PERIOD IN THERAPEUTIC 
HYPOTHERMIA: 
 The notion that therapeutic hypothermia in newborn should be started in 
less than six hours of life and continued for next 72hours are derived from the 
experiences gained from the animal experiments in this field so far. 
 According to the experiments some of the neurons are going to die in the 
acute phase of asphyxia. But neuronal death continues for the next 2-3 days of 
postnatal life –secondary neuronal death. This secondary neuronal death is 
attributed to various reasons-  
1.reperfusion injury 
2.cerebral edema- which is worse during the first 36- 92 hours of life 
3.calcium influx 
4.free radical scavenging 
5.increased apoptosis 
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once the clinical signs of these secondary neuronal damage such as seizures 
occurs hypothermia seems to be ineffective in preventing the subsequent 
inevitable death of further neurons. Thus there exist an window period – only 
during this early period therapeutic hypothermia seems to be effective in 
preventing neuronal deaths. 
As mentioned the period of 72 hours is also extrapolated from animal studies. 
As secondary neuronal death continues to occur upto 72 hours of life it is 
prudent to use hypothermia for that duration. apoptotic- necrotic continuum –
recent animal models have shown that there is a prolonged period of delayed 
cell death due to apoptosis –Nakajima et al 2000  
Why not greater than six hours? – This question in therapeutic hypothermia is a 
valuable one as greater number of newborns will be selected for cooling if the 
time period is extended. Only further clinical trials would help to clarify the 
issue. 
Various neuroprotective agents apart from hypothermia have been suggested 
These are 
Caspase inhibitors 
growth factors 
deferoxamine 
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free radical inhibitors- allopurinol, vitamin e 
nitric oxide synthase inhibitors 
calcium channel blockers 
GABA antagonists 
erythropoietin 
glycine’ 
phencyclidine 
magnesium binding site 
AMPA receptor antagonists 
 
 
 
ETIOLOGIES OF HYPOXIC –ISCHEMIC CHANGES: 
1. MATERNAL RISK FACTORS: 
hypertension 
hypotension 
infection- chorioamnionitis 
hypoxia from pulmonary or cardiac disorders 
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maternal vascular disorders 
cocaine  
abnormal placentation, 
abruption 
placental infarction 
fibromyoma 
rupture of the uterus 
cord prolapsed, knot, compression 
abnormalities of umbilical vessels 
 
 
 
 
 
 
2.Fetal factors 
  infection 
  anaemia 
  hydrops 
  severe cardiac insufficiency 
53 
 
3.neonatal factors. 
 cyanotic congenital heart diseases 
 persistent pulmonary hypertention 
 cardiomyopathies 
 various forms of septic shock and cardiogenic shock 
SEIZURES IN HYPOXIC ISCHEMIC ENCEPHALOPATHY: 
1. occur in about 50% of neonates with HIE 
2. usually starts less than twenty four hours of life 
3. seizures indicate that the severity is moderate or severe 
4. may be of the types- subtle, tonic or clonic 
5. jitteriness may be occasionally confused with 
6. often subclinical- only recorded by EEG  
7. EEG remains the gold standard in diagnosing 
8. compromise ventilation, oxygenation 
9. associated with poor developmental outcome 
10. EEG is required to detect electroclinical dissociation- subclinical 
seizures after starting anticonvulsants 
ANTICONVULSANTS IN PERINATAL HYPOXIA: 
1. phenobarbitone is the initial drug of choice 
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2. phenytoin may be added 
3. fos phenytoin is associated with less hypotensive effect 
4. benzodiazepines – third line drugs 
5. levetiracetam – used recently 
 
LONG TERM ANTICONVULSANT MANAGEMENT: 
1. anticonvulsants should be stopped when the clinical examination and 
Electroencephalography indicate that the newborn is no longer having 
seizures 
2. weaning should in reverse order of the drugs introduced 
3. some favour withdrawal phenobarbitone shortly before discharge 
4. some favour continued treatment for 1-6 months 
5. those with persistent neurological deficit and those with an abnormal 
EEG have high risk for developing recurrent seizures. 
 
NEUROLOGICAL MARKERS OF BRAIN INJURY IN PERINATAL 
HYPOXIA: 
1. CK-BB  
2. S-100 
3. neuron specific enolase 
55 
 
4. urine markers 
VARIOUS FORMS OF INJURY IN HIE 
1. FOCAL 
2. MULTIFOCAL 
3. WATERSHED INJURY 
4. SELECTIVE NEURONOL INJURY 
focal and multifocal injuries are associated with cystic changes 
watershed injuries- following severe hypotension –inbetween arterial 
territories – injury to parieto-occipital cortex 
selective neuronal –CA1 neurons of hippocampus is highly sensitive 
to hypoxia 
status marmoratus – necrosis of thalamic nuclei and basal ganglia is a 
variant of selective neuronal loss 
 
 
 
MULTIPLE ORGAN INVOLVEMENT IN PERINATAL 
HYPOXIA: 
1. One or more organ involvement occur in more than 80% of 
neonates with perinatal hypoxia. 
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2. central nervous system is the most common organ to be 
involved – about 70% 
3. the next common organ to be involved is kidney -45% 
4. pulmonary, cardiac and gastrointestinal system are the next 
common organs to be involved 
Acute perinatal asphyxia scoring system 
- used to predict multiple organ involvement in birth asphyxia 
- it components are 
-  1. 5 minute apgar score 
-  2. umbilical artery base deficit 
-  3. fetal heart rate monitor tracing 
- multiple organ involvement is more likely if the score is 
more than 6.  
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Gluckman Pd and Azoparrdi  they led the landmark study of therapeutic 
hypothermia and it was published in the lancet journal in 2005. 
Sankaran et al work on whole body hypothermia for neonates suffering from 
perinatal hypoxia was published in New England journal of medicine- 2005 
ACOG task force analysed the pathogenesis and pathophysiology behind 
perinatal asphyxia leading on to cerebral palsy. 
EEG during early periods of perinatal asphyxia can predict the 
neurodevelopmental outcomes at the age of 2 years –Murray in Paediatrics 2009 
The spectrum of clinical entities and predicting the outcomes in perinatal 
hypoxia is discussed by Walter C.Allan – Neoreviews 2002- American academy 
of paediatrics- state that the studies regarding the outcome in perinatal asphyxia 
is best guided by clinical assessment and EEG and both are readily available. 
An infant beginning to seek the nipple before the end of the second week of life 
– a optimistic sign towards the prognosis of the baby- Walter C Allan  
Outcome studies are disappointing for magnetic resonance imaging – likelihood 
ratios are not better than Electroencephalogram or evoked potentials. 
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OBSERVATION AND RESULTS: 
1. Total number of babies admitted in our unit with moderate to severe 
encephalopathy in the period of 7 months(from may 2012 to November 
2012) is 129 
2. out of 129 babies 50 babies received therapeutic hypothermia as a 
treatment- 
It is represented in the flow diagram as follows 
figure1. 
 
  
Among these 129 neonates 87 were delivered in our institution and 42
referred from other hospitals.(fig.1 and fig.2). Of the total 129 neonates 50 
received therapeutic hypothermia as a treatment modality. Every neonate was 
considered for therapeutic hypothermia treatment. Refusal of consent, arrival at 
greater than 6hrs of life or inability to initate cooling at 6 hrs of life, babies 
showing features of encephalopathy at greater than 6 hrs of life would fall in to 
non cooling group. In those babies who satisfy the inclusion criteria cooling will 
be started immediately as much as possible.
 
cooled
inborn-37
survived-24 died-13
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total 129
-50
outborn-13
survived 6 died-7
inborn-50
survived-31 died-19
 
 were 
non cooled 
- 79
outborn-29
survived-19 died-13
  
figure 2. 
 
1. Of the total number 129 neonates  52 died
mortality rate of 40.31%
2. Out of the 50 babies who underwent hypothermia as a treatment 
modality 20 neonates died 
3. Out of the 79 babies who were not cooled 
hypothermia and managed in a conventional manner 32 neonates have 
died – a mortality rate of 40.5%
4. Out of 37 inborn babies who underwent cooling  13 babies died 
mortality rate of  35.13%
cooled-50
survived-
30
died20
60 
- representing a combined 
 
– a mortality rate of 40% 
– not received therapeutic 
 
 
total 129
non 
cooled-79
survived-
47
 
– a 
died-32
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5. Out of 13 outborn babies who underwent cooling  7 died – a mortality 
rate of  53.84% 
6. Among the babies who underwent therapeutic hypothermia  2 babies 
died of pneumonia. These two babies have a prolonged hospital stay, 
with need for prolonged ventilator support compared to other babies 
who died without pneumonia. The duration of hospital stay was about 
40 days, and 21 days for the abovesaid  babies. In both of these babies 
blood cultures were negative. But in both of these babies Endo 
tracheal aspirate given for culture was positive for klebsillae  which 
was sensitive to piperacillin tazobactam and ciprofloxacin. So 
pneumonia as a contributory factor accounts for 10% of the mortality 
in the cooled babies. One of these babies required glucose infusion at 
6 mg/kg/min for hypoglycemia for 2 days. 
7. Out of the 20 babies died in the cooling cohort two baby had 
pulmonary haemorrhage as a complication. This would account for 
10% of the mortality in the cooled group. One of these babies 
developed apnea on day 1 life and required mechanical ventilator 
support on day 1 of life 
8. Out of the 20 babies died in the cooling cohort one baby developed 
cellulitis of right upper limb and died of refractory shock. 
9. Out of the 20 babies died in the cooling cohort one baby was found to 
have pneumothorax during admission. This baby was transported in 
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the ambulance and there is history of displacement of Endotracheal 
tube during the transport and the need for bag and mask ventilation 
during the transport. The pneumothorax was mild and was resolved on 
day 1 of life. Baby required ventilator support since admission and 
baby died of refractory shock on day 5 of life. 
10. Out of the 20 babies died in the cooling cohort 3 babies were found to 
have associated thrombocytopenia – a prevalence of 15% 
11. Out of the 6 babies who developed pneumonia in the cooling cohort 2 
babies died. That would amount to a mortality rate of 33% for 
pneumonia in these cohort. 
12. Out of the 20 babies died in the cooling cohort 6 were stage III. one 
baby with stage III HIE survived. This amount to mortality rate of 
85.7% mortality in stage III HIE. 
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ANANLYSIS OF MORTALITY: 
Mortality among cooled and Non cooling babies 
TABLE 1. 
 
No of Babies Cooled Non Cooling Group 
 
Total 
Survived 30 (60%) 47 (59.49%) 77 
Died 20 (40%) 32 (40.51%) 52 
Total 50 79 129 
 
P value = 0.954 > 0.05 there is no difference in the mortality among cooled and non cooled 
babies 
 
 
 FIGURE 3: 
: 
 
 
 
 
 
 
0
10
20
30
40
50
60
No of Babies Cooled
(P
e
rc
e
n
ta
g
e
)
Mortality among Cooled and Non Cooling 
64 
Non Cooling Group
Babies
Survived Died
 
65 
 
Mortality among inborn and out born babies of babies who underwent therapeutic 
hypothermia 
 TABLE 2: 
 
In born Out born  
 
Total 
Survived 24 (64.86%) 6 (46.15%) 30 
Died 13 (35.14%) 7 (53.85%) 20 
Total 37 13 50 
  
P value = 0.236 > 0.05 there is no difference in the mortality among cooled and non cooled 
babies 
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ANALYSIS OF MORBIDITY PATTERNS OF BABIES WHO 
UNDERWENT THERAPEUTIC HYPOTHERMIA: 
TABLE 3: 
Morbidity No .of Patients Percentage 
Bleeding-rectal 1 2 
Cellutis,thrombocy 1 2 
Pneumonia 6 12 
Pul haemorrhage 2 4 
Sc fat necrosis 2 6.6 
Sepsis 2 4 
Thrombocytopenia 2 4 
 
1. PERCENTAGE OF PNEUMONIA IN THE COOLED GROUP : Out of 
50 babies who underwent therapeutic hypothermia 6 babies developed 
pneumonia during the hospital course – an incidence of about 12% . As 
already mentioned out of the 6 babies with pneumonia 2 babies died. Out 
of the 4 babies with pneumonia and survived 2 babies were blood culture 
positive for klebsillae. 
2. Thus 2 babies were positive for blood culture out of  50 cooled babies and 
none of the babies who died in the cooling cohort have developed 
positive blood culture. This would amount to incidence of blood culture 
positive sepsis in the cooling cohort to 4% 
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3. Out of 30 babies who survived in the cooling cohort 2 babies developed 
subcutaneous fat necrosis with an estimated incidence of 6.66% in the 
alive babies 
 
4. Out of 30 babies who survived in the cooling cohort one baby developed 
rectal bleeding on day 3 of life- at the completion of cooling .rectal 
bleeding lasted for 2 days and the baby was transfused fresh frozen 
plasma twice. 
 
5. Out of 30 babies who survived in the cooling cohort one baby required 
exchange transfusion for hyperbilurinemia. Exchange transfusion was 
done on 5 th day of life. This baby showed features of HIE during early 
hours of life – well before the clinical evidence of hyperbilurinemia 
 
6. Out of 30 babies who survived in the cooling cohort one baby required 
umbilical vein cathetarisation during the hospital course as there is 
difficulty in securing a peripheral iv line. 
 
7. Out of 30 babies who survived in the cooling cohort all babies underwent 
neuroimaging modality by ultrasound cranium at approximately one week 
of life. Ultrasound cranium was normal in all the babies who survived. 
 
  
FIGURE 5: 
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Morbidity 
 
  
Gravida 
Primi 
G2 
G3 
G4 
 
TABLE 4: 
 
FIGURE 6: 
G2
12%
G3
4%
G4
4%
70 
No Percentage 
40 80 
6 12 
2 4 
2 4 
 
Primi
80%
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thus babies born to primi mothers contribute to majority share of  moderate to 
severe encephalopathy babies who were recruited for cooling theraphy. out of 
50 babies meconium stained liquour was present in 10 babies – about 20% 
 
 
TABLE 5: 
Nature of Delivery No. of patients Percentage 
Vaginal 43 86 
LSCS 2 4 
Forceps 5 10 
Total 50 100 
 
 
DELIVERING BY FORCEPS IS A SIGNIFICANT RISK FACTOR FOR HIE – AS IT IS 
INHERENT TO THE NATURE OF THE PROBLEM IN THAT FORCEPS IS USED IN 
DIFFICULT LABOUR 
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TABLE 6: 
 
 Yes Percentage 
O2 31 62 
CPAP 29 58 
Ventilator 25 50 
Phenobarbitone 46 92 
Phenytoin 11 22 
Midazolm 2 4 
Dopamine 36 72 
Dobutamine 26 52 
Adrenaline 5 10 
  
FIGURE 8: 
THUS WE CAN SEE THAT THERE IS NEED FOR 
SUPPORT IN NEARLY HALF OF NEONATES WITH MODERATE TO SEVERE 
ENCEPHALOPATHY 
ANTICONVULSANTS WERE USED IN THE MAJORITY THUS HIE STAGE II 
REPRESENTS THE MAJOR PORTION OF THE GROUP
THERE IS RELATIVELY HIGHER USAGE OF  INOTROPIC SUPPORT IN 
COHORT OF COOLED BABIES
 
 
 
TABLE 7: THUS THERE IS SIGNIFICANT PERCENTAGE OF NEONATES WHO 
UNDERWENT THERAPEUTIC HYPOTHERMIA
Babies survived 
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MECHANICAL VENTILATOR 
 
 
 SHOWS ABNORMALITY IN EEG
 
EEG Normal No of  babies with Abnormal EEG
 
THE 
 
 
 30 22 
  
Out of 30 babies survived 8 babies are not turn for the EEG. EEG was taken for 22 babies in 
5 babies EEG were abnormal. 
 No of  babies 
with EEG 
Taken
In born 17 
Out born 5 
TABLE 8: 
  20 % of the Out born babies having abnormal EEG and 23.5% of the In born babies having 
Abnormal EEG  
FIGURE 9: 
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17 (77.3%) 5 (23.7%) 
 
 
EEG Normal No of  babies with Abnormal EEG
13 (76.5%) 4 (23.5%)  
4 (80%) 1 (20%) 
Out born
Abnormal EEG
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TABLE 9: 
 EEG Normal EEG Abnormal 
N Mean + S.D N Mean + S.D 
Head of 
circumference  11 -1.453 + 0.751 4 -0.842 + 1.320 
weight  11 -1.783 + 1.585 4 -1.018 + 0.917 
Days of 
Hospitalisation 17 10.76 + 3.832 5 11.6 + 7.73 
 
 
 
 
 
 
 
TABLE 10: 
 
 
 No of patients Mean Standard Deviation 
Birth Weight 45 2.816 0.367 
Days of 
Hospitalisation  50 9.38 6.872 
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TABLE 11: 
Comparison of Head Circumference between Cooled and Well babies  
 
Babies 
No of patients Mean Standard Deviation P value 
Cooled babies 17 -1.174 0.230 
0.014 
Well Babies 19 -0.285 0.266 
 
 Average Head circumference of cooled babies is -1.174 and well babies is -0.285 with 
the p value <0.05 there is a significant difference in head circumference between both the 
babies   
Comparison of weight between Cooled and Well babies TABLE 12: 
 
Babies 
No of patients Mean Standard Deviation P value 
Cooled babies 17 -1.385 0.268 
0.035 
Well Babies 19 -0.588 0.245 
 
Average Head circumference of cooled babies is -1.385 and well babies is -0.588 with 
the p value <0.05 there is a significant difference in head circumference between both the 
babies   
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DISCUSSION: 
1. MORTALITY: 
From the data we can observe a relatively higher mortality rate for 
moderate to severe encephalopathy overall than that reported in 
developed countries.  
This can be attributed to possible high incidence of 
associated meconium stained liquour in considerable proportions 
and relatively higher incidence of bacterial sepsis and pneumonia 
in these babies. 
 The overall mortality rate reported in developed countries is 
about 20%.  The mortality rate are comparatively higher in 
developing countries like India. 
 In our study the overall mortality rate for both stage II and 
stage III Hypoxic ischemic encephalopathy was 40% . 
 It should be noted that stage I Hypoxic ischemic 
encephalopathy babies were not included in this study that would 
otherwise reduced the overall mortality. 
 The mortality rate among cooled and non cooled groups 
were similar – around 40% and difference if any was statistically 
significant.  
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Thus it can be concluded that therapeutic hypothermia in a 
level II nicu setting by using low cost technology does not alter the 
mortality rate of Hypoxic encephalopathy babies. 
 
 The mortality rate was considerably higher in those babies 
referred to the hospital than the babies who were born at the 
hospital-53.85% and 35.15 % respectively – although the statistical 
analysis showed that difference was insignificant – the probable 
explanation would be relative difference in the resuscitation at birth 
in peripheral hospital and condition prevailing during transport.  
 These factors can adversely affect the physiological state of 
the newborn during admission affecting the mortality thereby. 
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MORBIDITY: 
  The commonest morbidity among the neonates with moderate to  
severe encephalopathy was pneumonia. The incidence of 
pneumonia was higher in this population about 12%.  
Among the 6 cases of pneumonia 2 were blood culture 
positive for klebsillae and 2 were ET aspirate culture positive for 
klebsillae. This could possibly attributed to relatively higher 
incidence of early onset sepsis and hospital acquired infection in 
this group of neonates 
 Bleeding in the form of pulmonary haemorrhage and rectal 
bleeding occurred in significant propotion of cases in cooled group. 
Most of the babies in the cooling group showed prolonged 
coagulation profiles and majority of them received fresh frozen 
plasma. 
Bleeding also occurred in non cooling group- about 3.6%. 
Hence there is no difference in the rate of bleeding tendency 
between cooled and non cooled group. 
 Out of the 30 babies who survived 2 babies were found to 
have subcutaneous fat necrosis. Similar rates were reported in other 
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study regarding therapeutic hypothermia in neonates. These 2 
babies were otherwise normal clinically. 
 
 
EEG: 
   As we can see from the results that significant propotion  
  about 22% (nearly one fourth) of the neonates who underwent  
  therapeutic hypothermia showed abnormalities.None of the 30  
  babies who survived have seizures or developmental delay as a  
  concern by the parents. 
 All the babies with abnormal EEG were  
  normal by neurological examination and normal by developmental  
  assessment by Denver Developmental Screening Test- DDSTII 
  It should be noted only 23 patients out of 30 patients turned out for 
  EEG examinations. 
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 Developmental Assessment: 
   Developmental Assessment using denver developmental 
  screening test was carried out in all the babies who underwent thera
  -peutic hypothermia in the month of December by two sessions .
  Each babies was examined at approximately 10 minutes time. 
  All the babies who was examined were having normal  
  developmental screening test. Only 22 out of 30 survivors turned 
  out for the screening test. This proves to the fact that most of HIE 
  II babies have a normal neurodevelopmental outcome.    
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ANTHROPOMETRIC MEASUREMENTS: 
 All the babies on follow up found to lag behind in terms of weight gain 
and the head circumference compared to similar age group infants found in well 
baby clinics in our institution 
This may be partly explained by the nutritional deprivation during the 
hospital course, failure of lactation in the mother due to failure to initiate 
lactation immediately after birth. 
 Expressing the breast milk in the mothers of babies with perinatal 
hypoxia would probably help to sustain the lactation in the mother. 
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CONCLUSION: 
 There is significant proportion of neonates who underwent therapeutic 
hypothermia showed abnormalities in the electroencephalogram at the age of 
one month. Repeated neurological examination and serial EEG and possibly 
MRI would aid in the management of this subgroup of neonates.  
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3. USE OF GEL PACKS IN THERAPEUTIC HYPOTHERMIA 
 
4. RECTAL TEMPERATURE BEING MONITORED VIA RECTAL PROBE  
S.NO NAME OF THE PATIENT IP NO SURVIVED/DEAD MOTHER DETAILS NATURE OF DELIVERY APGAR BIRTH WEIGHT SEX INBORN/OUTBORN O2 CPAP VENTILATOR PHENOBARBITONE PHENYTOIN MIDAZOLAM DOPAMINE DOBUTAMINE
1 B/O THILAGA 16506 S G2 - PIH VAGINAL 3--4 2.25 M I Y N N Y N N N N
2 B/O SASIKALA 18863 S G3 VAGINAL 3--5 3.6 F I Y Y Y Y N N Y Y
3 B/O CHITRA 19268 S PRIMI VAGINAL 3 M O N N N Y N N N N
4 B/O UMAMAHESWARI 20396 S PRIMI- CORD -NECK VAGINAL 4--5 2.9 M I Y N N Y N N N N
5 B/O JEYALAKSHMI 20969 S PRIMI VAGINAL 4--6 2.3 M I Y N N Y N N Y N
6 B/O HEMAVATHY 31449 S PRIMI VAGINAL 4--5 3.2 M I Y N N Y N N Y Y
7 B/O JAMUNARANI 32202 S PRIMI VAGINAL 2.75 F O Y N N Y Y N N N
8 B/O ANGAMMAL 32799 S PRIMI VAGINAL 3--5 3.2 M I Y Y N Y N N N N
9 B/O THAMARAISELVI 33723 S PRIMI VAGINAL 3 M O N N N Y Y N N Y
10 B/O RADHIKA 33927 S PRIMI VAGINAL 3--6 2.8 F I Y Y Y Y N N Y N
11 B/O SHARMILA 35154 S PRIMI VAGINAL 3.5 M O Y Y N Y Y N N N
12 B/O NANDHINI 36445 S SHORT PRIMI VAGINAL 2--4 2.625 M I N N N Y N N Y Y
13 B/O SEETHALAKSHMI 36907 S PRIMI VAGINAL 4--6 2.8 F I Y Y N Y Y N Y N
14 B/O MUNIYAMMAL 40499 S PRIMI VAGINAL 4--5 2.8 M I Y Y N Y N N Y N
15 B/O KANAGA 29051 S PRIMI VAGINAL NA 2.8 M O Y Y Y Y Y Y N N
16 B/O SELVI 30577 S G4 VAGINAL 4--5 2.93 M I Y Y N Y N N Y N
17 B/O PARVATHY 31200 S PRIMI VAGINAL 4--6 2.39 M I Y Y Y Y N N Y N
18 B/O LAVANYA 35394 S PRIMI VAGINAL NA 2.905 M O N N N Y N N Y N
19 B/O MALAR 41089 S G4+MSAF LSCS 5--7 3 M I Y N N Y N N N N
20 B/O PRIYA 41063 S PRIMI/PIH VAGINAL 3--5 2.5 F I Y Y N Y N N N N
21 B/O SREEDEVI 42773 S PRIMI FORCEPS 5--6 2.8 M I Y Y Y Y Y N Y N
22 B/O SANGEETHA 42512 S G2 VAGINAL 4--6 3.8 F I Y Y N Y N N N Y
23 B/O EZZHILRANI 43129 S PRIMI VAGINAL 3--6 3.15 M I Y N N Y N N Y N
24 B/O GNAMMAL 44753 S PRIMI VAGINAL 4--6 3.05 M I Y N N Y N N Y N
25 B/O MOHANA 44939 S PRIMI VAGINAL 5--7 2.15 F I Y N N Y N N Y N
26 B/O SANDHYA 44218 S PRIMI VAGINAL NA 2.7 M I Y N N Y N N N N
27 B/O SARIDHA 45317 S PRIMI VAGINAL NA 2.4 M I Y Y N Y Y N N Y
28 B/O PARIMALA 42938 S PRIMI FORCEPS 5--6 3 M I Y Y N Y N N Y N
29 B/O PREMA 37120 S G2 VAGINAL 5--6 3.3 M I Y Y N Y Y N Y N
30 B/O SHANTHI 46075 S G2 VAGINAL 5--7 3.2 F I Y N N Y N N N N
31 B/O NEELA 16350 D PRIMI VAGINAL NA 2.75 M O Y Y Y Y N Y Y Y
32 B/O AMBIKA 18158 D PRIMI+MSAF VAGINAL 2--4 2.8 M I N N Y Y N N Y Y
33 B/O SANGEETHA 18838 D PRIMI VAGINAL 3--5 2.6 M I Y Y Y N N N Y Y
34 B/O MALINI 16423 D PRIMI VAGINAL 3--5 2.85 F I N N Y Y N N Y Y
35 B/O VIJAYA 23408 D G2 VAGINAL 2--4 2.5 F I N N Y Y N N Y Y
36 B/O DHATCHAYANI 18940 D PRIMI FORCEPS 2--4 2.5 M I Y Y Y Y N N Y Y
37 B/O LAKSHMI 25688 D PRIMI VAGINAL 4--5 2.7 F I N N Y Y N N Y Y
38 B/O SATHYA 24073 D PRIMI+MSAF VAGINAL NA 2.3 M I N Y Y Y N N Y Y
39 B/O PADMAVATHY 23570 D PRIMI VAGINAL NA 2.9 F I N Y Y N N N Y Y
40 B/O AIYSHA 30473 D G3 VAGINAL 4--4 2.5 M I N N Y Y N N Y Y
41 B/O CHITRA 32163 D PRIMI LSCS 4--5 2.7 M I N Y Y N N Y Y
42 B/O SANGEETHA 28918 D PRIMI VAGINAL 4--5 2.87 M I Y Y Y Y N N Y Y
43 B/O SATHYA 36916 D PRIMI FORCEPS 3--6 2.47 M I N Y Y y N N Y Y
44 B/O VIJI 38868 D PRIMI VAGINAL NA 2.8 F O Y Y Y Y Y N Y Y
45 B/O ELAVARASI 38500 D PRIMI VAGINAL NA 2.3 F O N Y Y Y Y N Y Y
46 B/O SUMATHI 38433 D PRIMI VAGINAL NA 3.45 M O N N Y Y Y N Y Y
47 B/O NEELAKODI 40951 D PRIMI VAGINAL NA 3.065 M O N Y Y Y N N Y Y
48 B/O SUDHA 43523 D PRIMI VAGINAL NA 2.9 M I N Y Y Y N N Y Y
49 B/O ROJA 44145 D G2 FORCEPS NA 2.75 F I N Y Y Y N N Y Y
50 B/O SHARMILA 35377 D PRIMI+MSAF VAGINAL 2--3 2.6 F O N Y Y Y N N Y Y
S.NO ADRENALINE MORBIDITY DAYS OF HOSPITALISATION HEAD CIRCUMFERENCE WEIGHT DENVER II EEG EEG-COMMENTS OTHER REMARKS
1 N 11 REFUSED
2 N 20 NORMAL
3 N 8 -1.41 -0.41 PASS NORMAL
4 N 9 -1.28 -2.22 PASS ABNORMAL RIGHT FRONTO PARIETAL SPIKES
5 N BLEEDING-RECTAL 6 PASS NORMAL RECTAL BLEEDING
6 N PNEUMONIA 18 -1.23 0.11 PASS NORMAL
7 N 8 -2.57 -2.43 PASS NORMAL C/O DROOLING OF SALIVA
8 N 11 -0.7 -0.39 PASS NORMAL
9 N 8 -1.82 -1.98 PASS NORMAL
10 N SC FAT NECROSIS 9 0.98 -0.53 PASS ABNORMAL BIL EPILEPTIFORM ACTIVITY
11 N 5 -2.15 -0.12 PASS ABNORMAL BIL EPILEPTIFORM ACTIVITY
12 N SEPSIS 11 -2.25 -5.41 PASS NORMAL CULTURE POSITIVE FOR KLEBSILLA
13 N 11 PASS NORMAL
14 N 9 PASS NORMAL C/O EPISODIC UPWARD GAZE
15 N PNEUMONIA 20 UVC WAS USED
16 N 13 PASS NORMAL SINGLE CAFÉ-U-LAIT SPOT
17 N PNEUMONIA 25 ABNORMAL CULTURE POSITIVE FOR KLEBSILLA
18 N 12 NORMAL EXCHANGE TRANSFUSION FOR HYPERBILURUNEMIA
19 N SC FAT NECROSIS 8 ABSCONDED 
20 N 10 -2.3 -2.91 PASS NORMAL
21 N 5
22 N 8 0.52 0.09 PASS
23 N 8 DISCHARGE AT REQUEST
24 N 10 -0.36 -0.73 PASS NORMAL
25 N 6 -1.63 -2.21 PASS NORMAL
26 N 9 -1.56 -2.23 PASS
27 N 18 -1.81 -3.13 PASS
28 N 14 -1.28 -2.49 PASS NORMAL
29 N 10 -0.92 -1.2 PASS ABNORMAL
30 N 8 -0.44 -0.76 PASS NORMAL
31 N PUL HAEMORRHAGE 4 APNEA ON DAY 1
32 N 2
33 Y 4
34 N 6
35 N 4 STAGE III
36 Y PNEUMONIA 40 ET ASPIRATE POSITIVE FOR KLEBSILLAE
37 N 3
38 N <1
39 N 4
40 N THROMBOCYTOPENIA 7
41 N <2
42 N PNEUMONIA 21 ET ASPIRATE POSITIVE FOR KLEBSILLAE
43 N THROMBOCYTOPENIA 3
44 Y 5
45 N PNEUMOTHORAX 5 PNEUMOTHORAX ON ADMISSON/ ET DISPLACED DURING TRANSPORT
46 N PUL HAEMORRHAGE 5
47 N 5
48 Y 6
49 N CELLUTIS,THROMBOCY 8
50 Y 6
